Stock Taper
IQV
IQVIA HOLDINGS INC.
NYSE
$271.62
▲ UP 2.95% (7.78)

KEY STATISTICS

Market Cap$44.44 B
52w High$271.67
52w Low$154.50
Dividend Yield
Frequency
P/E22.39
Volume1.95M
Shares Out.164.60M

COMPANY

LEADERSHIP

Ari Bousbib
CHIEF EXECUTIVE
Ari Bousbib

COMPENSATION 2026

Salary$1,800,000
Stock Awards$15,749,957
Incentive Plan Pay$0
All Other Comp.$393,996
Total$28,128,245

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 9, 2013
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
94,000

PRICE TARGET

Target High$287.00
Target Low$185.00
Target Median$240.00
Target Consensus$237.38

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$4.36B
NOV
3
TUE

PRICE

$271.62 ▲ UP 2.95% (+$7.78)
$265$268$2709:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM271.62

About IQVIA Holdings Inc.

https://www.iqvia.com ↗

IQVIA Holdings Inc. provides analytics, technology, and clinical research services to the global life sciences industry across three segments: Technology & Analytics, R&D Solutions, and Contract Sales & Medical Solutions.

INDUSTRY

Medical - Diagnostics & Research

A SERVICE IQVIA HOLDINGS INC. IS KNOWN FOR

IQVIA AI and AI Agents for Life Sciences

IQVIA's AI-powered agents enhance the entire life sciences value chain, from R&D to commercialization, by leveraging healthcare data to drive innovation and efficiency in the industry.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Technology And Analytics Solutions$1.63B $3.45B $3.55B
Research And Development Solutions$2.26B $4.53B $2.4B $2.58B
Contract Sales And Medical Solutions$209M $398M

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
Americas$1.93B $4B $1.98B $2.04B
EMEA$1.3B $2.66B $1.35B $1.41B
Asia Pacific$870M $1.71B $812M $920M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets4
Debt To Equity1
Price To Earnings2
Price To Book2
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Kevin Hern
Kevin Hern
Sale
2026-03-16
Ro Khanna
Ro Khanna
Sale
2026-01-29
SENATE TRADES
Markwayne Mullin
Markwayne Mullin
Purchase
2025-12-29
John Boozman
John Boozman
Sale (Partial)
2025-10-02

INSIDER TRADES

OFFICER: SEE REMARKS
Patel Bhavik
Sale · 1.9K shares
2026-07-31
OFFICER: SEE REMARKS
STAUB W RICHARD
Sale · 5.5K shares
2026-08-03
DIRECTOR, OFFICER: SEE REMARKS
BOUSBIB ARI
Sale · 53.2K shares
2026-07-29
DIRECTOR, OFFICER: SEE REMARKS
BOUSBIB ARI
Sale · 2.1K shares
2026-07-29

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
OUTPERFORM 5
OVERWEIGHT 2
EQUAL WEIGHT 1
NEUTRAL 1
15 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
CAH$248.94COMPARE
HUM$408.43COMPARE
HLN$9.79COMPARE
A$149.77COMPARE
ALC$72.11COMPARE
RMD$229.82COMPARE
ILMN$216.03COMPARE
GEHC$69.52COMPARE